Kerr JS - Search Results

1

Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesis.

Wright SW, Harris RR, Kerr JS, Green AM, Pinto DJ, Bruin EM, Collins RJ, Dorow RL, Mantegna LR, Sherk SR, et al. Wright SW, et al. Among authors: kerr js. J Med Chem. 1992 Oct 30;35(22):4061-8. doi: 10.1021/jm00100a011. J Med Chem. 1992. PMID: 1433212

2

2'-substituted chalcone derivatives as inhibitors of interleukin-1 biosynthesis.

Batt DG, Goodman R, Jones DG, Kerr JS, Mantegna LR, McAllister C, Newton RC, Nurnberg S, Welch PK, Covington MB. Batt DG, et al. Among authors: kerr js. J Med Chem. 1993 May 14;36(10):1434-42. doi: 10.1021/jm00062a016. J Med Chem. 1993. PMID: 8496911

3

An evaluation of 2-benzyl-1-naphthol (DuP 654) analogs as systemic anti-inflammatory agents.

Kerr JS, Batt DG, Pinto DJ, Stampfli HF. Kerr JS, et al. Res Commun Chem Pathol Pharmacol. 1992 Jul;77(1):77-86. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1439183

4

Phospholipase A2 (PLA2) activity in bovine pulmonary artery endothelial cells.

Goodman R, Stevens TM, Mantegna LR, Kidd PR, Harris RR, Kerr JS. Goodman R, et al. Among authors: kerr js. Agents Actions. 1991 Sep;34(1-2):113-6. doi: 10.1007/BF01993253. Agents Actions. 1991. PMID: 1793014

5

IL-1 and its role in rat carrageenan pleurisy.

Goodman R, Mantegna LR, McAilister CL, Bruin E, Dowling RL, George H, Feeser W, Freimark B, Lischwe M, Pick S, Harris RR, Kerr JS. Goodman R, et al. Among authors: kerr js. Mediators Inflamm. 1993;2(1):33-9. doi: 10.1155/S0962935193000043. Mediators Inflamm. 1993. PMID: 18475500 Free PMC article.

6

Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes.

Kerr JS, Stevens TM, Davis GL, McLaughlin JA, Harris RR. Kerr JS, et al. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1079-84. doi: 10.1016/0006-291x(89)92712-5. Biochem Biophys Res Commun. 1989. PMID: 2558648

7

Phospholipase A2 (PLA2) activity in undifferentiated U937 cells.

Galbraith W, Paschetto KA, Stevens TM, Kerr JS. Galbraith W, et al. Among authors: kerr js. Agents Actions. 1989 Jun;27(3-4):422-4. doi: 10.1007/BF01972840. Agents Actions. 1989. PMID: 2678955

8

The characterization of potent novel warfarin analogs.

Kerr JS, Li HY, Wexler RS, Robinson AJ, Robinson CS, Boswell GA, Krauthauser C, Harlow PP. Kerr JS, et al. Thromb Res. 1997 Oct 15;88(2):127-36. doi: 10.1016/s0049-3848(97)00224-7. Thromb Res. 1997. PMID: 9361366

9

Phospholipase A2 (PLA2) activity in rabbit chondrocytes.

Stevens TM, Chin JE, McGowan M, Giannaras J, Kerr JS. Stevens TM, et al. Among authors: kerr js. Agents Actions. 1989 Jun;27(3-4):385-7. doi: 10.1007/BF01972829. Agents Actions. 1989. PMID: 2801329

10

Characterization of extracellular phospholipase A2 (PLA2) activity in fluid and peritoneal cells from casein-treated rats.

Stevens TM, McGowan M, Giannaras J, Kerr JS. Stevens TM, et al. Among authors: kerr js. Inflammation. 1990 Aug;14(4):389-99. doi: 10.1007/BF00914090. Inflammation. 1990. PMID: 2379954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters